Nini de Boer

ORCID: 0000-0002-4956-3555
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Diet and metabolism studies
  • Diabetes Treatment and Management
  • Alcohol Consumption and Health Effects
  • Pharmaceutical Practices and Patient Outcomes
  • Peripheral Neuropathies and Disorders
  • Pharmacovigilance and Adverse Drug Reactions
  • Bipolar Disorder and Treatment
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Substance Abuse Treatment and Outcomes
  • Cardiovascular Syncope and Autonomic Disorders
  • Parkinson's Disease Mechanisms and Treatments
  • Digital Mental Health Interventions
  • Smoking Behavior and Cessation
  • Obsessive-Compulsive Spectrum Disorders
  • COVID-19 and Mental Health
  • Autoimmune Neurological Disorders and Treatments
  • Telemedicine and Telehealth Implementation

University Medical Center Utrecht
2021-2025

Utrecht University
2021-2025

Marte Z. van der Horst Nini de Boer Ahmet Müderrisoğlu Alba Toll Alde Bouhuis and 85 more Alkomiet Hasan Amy Jongkind Ana González‐Pinto Anna Mané Armando D’Agostino Aygün Ertuğrul A. Elif Anıl Yağcıoğlu Benedicto Crespo‐Facorro Bernhard T. Baune Bianca Sánchez-Barbero Carlos Spuch Carla Lou Morgenroth Carmen Fernandez de Pinedo Cecilia Casetta Chad A. Bousman Christa Hohoff Christos Pantelis Claudia Ovejas-Catalán Clemente García-Rizo Dan Cohen Dragana Ignjatović Ristić Edwin Beld Eila Repo‐Tiihonen Elias Wagner Ellen Jeger-Land Elisabet Vilella Emilio Fernández-Egea Erwin Bekema Esteban Sepúlveda Federico Wiedenmann Francesca Martini Francesca Serio Francesca Vairano Giacomo Mercuriali Giovanni Boido Gökhan Yoca Hanneke van Beek Harm J. Gijsman Heli Tuppurainen Ian Everall Ivona Novakovic Eric P. Zorrilla İbrahim Mert Erdoğan Jacopo Sapienza Jan Bogers Jari Tiihonen Javier Vázquez‐Bourgon Jim van Os Johannes Schneider‐Thoma Jurjen J. Luykx Koen P. Grootens Lorea Mar-Barrutia Lourdes Martorell Maarten Bak Marco Spangaro M. Zierhut Marije de Vos Mariken de Koning Marina Garriga Markku Lähteenvuo Marta Bosia Marte Z. van der Horst Melih O. Babaoğlu Mike Veereschild Mirko Manchia Mishal Qubad Monika Edlinger Paloma Fuentes-Pérez Pasquale Paribello Purificación López-Peña René S. Kahn Robert A. Bittner Roberto Cavallaro Selene Veerman Stefan Gutwinski Stefanie Schreiter Stephan Ripke Tania Rivera Baltanás Tatiana Oviedo-Salcedo Tero Hallikainen Thomas Görlitz Wouter Alink Yavuz Ayhan Cynthia Okhuijsen‐Pfeifer Jurjen J. Luykx

Clozapine is highly effective for treatment-resistant schizophrenia but underutilized due to patient and clinician-related concerns. Little known about the general level of satisfaction with clozapine determinants thereof. We therefore explored in individuals diagnosed spectrum disorders (SSDs). Cross-sectional data from 480 users were used examine demographic clinical factors, including symptom severity, treatment response, adverse drug reactions (ADRs). Patient was self-rated on a scale 1...

10.1038/s41537-025-00570-9 article EN cc-by-nc-nd Schizophrenia 2025-02-23
Marte Z. van der Horst Yoeki Meijer Nini de Boer Sinan Gülöksüz Alkomiet Hasan and 86 more Dan Siskind Elias Wagner Cynthia Okhuijsen‐Pfeifer Jurjen J. Luykx Ahmet Müderrisoğlu Alba Toll Alde Bouhuis Alkomiet Hasan Amy Jongkind Ana González‐Pinto Anna Mané Armando D’Agostino Aygün Ertuğrul A. Elif Anıl Yağcıoğlu Benedicto Crespo‐Facorro Bianca Sánchez-Barbero Carlos Spuch Carla Lou Morgenroth Carmen Fernandez de Pinedo Cecilia Casetta Chad A. Bousman Christos Pantelis Claudia Ovejas-Catalán Clemente García-Rizo Cynthia Okhuijsen‐Pfeifer Dan Cohen Dragana Ignjatović Ristić Edwin Beld Eila Repo‐Tiihonen Elias Wagner Ellen Jeger-Land Elisabet Vilella Erwin Bekema Stevan Sepúlveda F. Seghi Federico Wiedenmann Francesca Martini Francesca Serio Francesca Vairano Giacomo Mercuriali Giovanni Boido Gökhan Yoca Hanneke van Beek Harm J. Gijsman Heli Tuppurainen Ian Everall Ivona Novakovic Eric P. Zorrilla İbrahim Mert Erdoğan Jacopo Sapienza Jan Bogers Jari Tiihonen Javier Vázquez‐Bourgon Jim van Os Johannes Schneider‐Thoma Jurjen J. Luykx Koen P. Grootens Lorea Mar-Barrutia Lourdes Martorell Maarten Bak Marco Spangaro Marije de Vos Mariken de Koning Marina Garriga Markku Lähteenvuo Marta Bosia Marte Z. van der Horst Melih O. Babaoğlu Mike Veereschild Mirko Manchia Monika Edlinger Paloma Fuentes-Pérez Pasquale Paribello Purificación López-Peña René S. Kahn Roberto Cavallaro Selene Veerman Stefan Gutwinski Stefanie Schreiter Stephan Ripke Tania Rivera Baltanás Tatiana Oviedo-Salcedo Tero Hallikainen Thomas Görlitz Wouter Alink Yavuz Ayhan

Clozapine is often underused due to concerns about adverse drug reactions (ADRs) but studies into their prevalences are inconclusive. We therefore comprehensively examined of clozapine-associated ADRs in individuals with schizophrenia and demographic clinical factors associated occurrence. Data from a multi-center study (n=698 participants) were collected. The mean number during clozapine treatment was 4.8, 2.4% participants reporting no ADRs. most common hypersalivation (74.6%), weight gain...

10.1016/j.psychres.2023.115539 article EN cc-by Psychiatry Research 2023-10-11

Previous studies into mental health service utilisation during the COVID-19 pandemic are limited to a few countries or specific type of service. In addition, data on changes in telepsychiatry currently lacking.We aimed investigate whether is associated with utilisation, including telepsychiatry, and how these were distributed among patients illness first outbreak.This retrospective study obtained routinely assessed healthcare from large Dutch institute. Data second quarter 2020 (the outbreak...

10.1192/bjo.2021.1049 article EN cc-by-nc-nd BJPsych Open 2021-11-01

Alcohol consumption, smoking and mood disorders are leading contributors to the global burden of disease highly comorbid. Yet, their interrelationships have remained elusive. The aim this study was examine multi-cross-sectional longitudinal associations between (change in) alcohol use number depressive symptoms.In prospective, study, 6646 adults from general population were included with follow-up measurements after 3 6 years. Linear mixed-effects models used test associations, behaviour,...

10.1017/s0033291721002968 article EN cc-by Psychological Medicine 2021-08-11

Abstract Background Antipsychotic-induced Weight Gain (AiWG) is a debilitating and common adverse effect of antipsychotics. AiWG negatively impacts life expectancy, quality life, treatment adherence, likelihood developing type-2 diabetes readmission. Treatment currently challenging, there no consensus on the optimal management strategy. In this study, we aim to evaluate use metformin for by comparing with placebo in those receiving as usual, which includes lifestyle intervention. Methods...

10.1186/s12888-020-02992-4 article EN cc-by BMC Psychiatry 2021-01-05
Coming Soon ...